fashion -WSS

fashion

author：Wikipedia 2025-08-28 03:35:17 - browse：4238

Maze Therapeutics CEO Jason Coloma Courtesy

After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.

Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional, undisclosed payments if the oral medication, which is in clinical testing, meets certain regulatory and commercial goals.

Last year, Sanofi, the French pharma giant, was set to pay $150 million in cash and stock to Maze before the transaction fell apart.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Study fuels hope CAR

leisure time

WSS

CDC panel: People 65 and older should get a Covid spring booster shot

Using force crossed my mind when examining a defiant young patient

Watch the official trailer for 'Ahsoka' series

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Study fuels hope CAR

STAT Madness 2024: Meet the contenders

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Virginia high school admissions case could be legal follow

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

ChatGPT in medicine: STAT answers readers' burning questions

The debate over Covid

Malaria cases in Florida and Texas: Here’s what you need to know

CDC advisory group OKs chikungunya vaccine

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

'Vaccine

ChatGPT in medicine: STAT answers readers' burning questions

Medicare Advantage isn’t working — for anyone

focus

'Vaccine

CDC panel: People 65 and older should get a Covid spring booster shot

Color Health wants to make cancer screenings convenient

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Medicare isn't yet testing food as medicine

Elisabeth Bik tackles the widespread issue of research misconduct

Wikipedia

Wikipedia

leisure time

focus